Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TACE Combined With Microwave Ablation for Huge Unresectable Hepatocellular Carcinoma
NCT03277716Unknown
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial in hepatocellular carcinoma (HCC). Primary endpoint: Overall Survival at 3 years. Status: unknown.
02
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03277716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03277716.